Evidence map›Paper›PMID 27431050›Full record

Trial reportJournal of substance abuse treatment2016

Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders.

Mary Hatch-Maillette, Elizabeth A Wells, Suzanne R Doyle, Gregory S Brigham, Dennis Daley, Jessica DiCenzo, Dennis Donovan, Sharon Garrett, Viviana E Horigian, Lindsay Jenkins and 3 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of substance abuse treatment, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Review
  4. Review
  5. Article
  6. Harm Reduction-Oriented Occupational Therapy for Substance Use Disorders: A Retrospective Cohort Study.The American journal of occupational therapy : official publication of the American Occupational Therapy Association
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 1 country.

Mary Hatch-MailletteUniversity of Washington Alcohol and Drug Abuse Institute, 1107 NE 45th St., Suite 120, Seattle, WA 98105; University of Washington School of Medicine, Department of Psychiatry and Behavioral Sciences, 1959 NE Pacific St., Seattle, WA 98105. Electronic address: hatchm@uw.edu.
Elizabeth A WellsUniversity of Washington Alcohol and Drug Abuse Institute, 1107 NE 45th St., Suite 120, Seattle, WA 98105; University of Washington School of Social Work, 4101 15th Ave NE, Seattle, WA 98105.
Suzanne R DoyleUniversity of Washington Alcohol and Drug Abuse Institute, 1107 NE 45th St., Suite 120, Seattle, WA 98105.
Gregory S BrighamAdapt & SouthRiver Community Health Center, Roseburg, OR 97470.
Dennis DaleyUniversity of Pittsburgh School of Medicine, Department of Psychiatry, Western Psychiatric Institute and Clinic, 3811 O'Hara St, Pittsburgh, PA 15213.
Jessica DiCenzoSan Francisco General Hospital, 1001 Potrero Ave., San Francisco, CA 98110.
Dennis DonovanUniversity of Washington Alcohol and Drug Abuse Institute, 1107 NE 45th St., Suite 120, Seattle, WA 98105; University of Washington School of Medicine, Department of Psychiatry and Behavioral Sciences, 1959 NE Pacific St., Seattle, WA 98105.
Sharon GarrettUniversity of Washington Alcohol and Drug Abuse Institute, 1107 NE 45th St., Suite 120, Seattle, WA 98105.
Viviana E HorigianUniversity of Miami Department of Public Health Sciences, Miller School of Medicine, 1120 NW 14th St., Miami, FL 33136.
Lindsay JenkinsMultnomah County Health Department, 426 SW Stark St, Portland, OR 97204.
Therese KilleenMedical University of South Carolina Department of Psychiatry and Behavioral Sciences, 67 President St., Charleston, SC 29425.
Mandy OwensUniversity of New Mexico Center on Alcoholism, Substance Abuse and Addictions, 2650 Yale Blvd SE, Albuquerque, NM 87106.
Harold I PerlIndependent Consultant, P.O. Box 169, Arroyo Seco, NM 87514.
Seattle Indian Health Board · USArroyo Grande Community Hospital · USCommunity Health Center · USMedical University of South Carolina · USMultnomah County Health Department · USSan Francisco General Hospital · USUniversity of Miami · USUniversity of New Mexico · USUniversity of Pittsburgh · USUniversity of Washington · US

Funding

Project-004UG1DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI Steven J Shoptaw, MADHUKAR H. TRIVEDI · 2015 to 2026
$71.6M
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORKU10DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI METSCH, LISA R, SZAPOCZNIK, JOSE · 2000 to 2015
$56.9M
The National Drug Abuse Treatment Clinical Trials NetworkU10DA013045 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LING, WALTER NMN · 1999 to 2015
$52.6M
Clinical Trials Network, Ohio Valley Node U10DA013732U10DA013732 · NIDA · UNIVERSITY OF CINCINNATI · PI WINHUSEN, T JOHN · 2000 to 2015
$45.0M
Southern Consortium Node of the Clinical Trials NetworkU10DA013727 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2000 to 2015
$34.4M
CLINICAL TRIALS NETWORK: PACIFIC NORTHWEST NODEU10DA013714 · NIDA · UNIVERSITY OF WASHINGTON · PI DONOVAN, DENNIS MICHAEL, ROLL, JOHN M. · 2001 to 2015
$25.5M
Concept ProjectU10DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI TRIVEDI, MADHUKAR H. · 2005 to 2015
$22.6M
OREGON NODE - NATIONAL CLINICAL TRIALS NETWORKU10DA013036 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI MCCARTY, DENNIS · 1999 to 2010
$18.5M
CLINICAL TRIAL RESEARCH PROJECT COREU10DA020036 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DALEY, DENNIS C · 2005 to 2015
$14.1M
NIDA NIH HHS U10 DA013036NIDA NIH HHS U10 DA013045NIDA NIH HHS U10 DA013714NIDA NIH HHS U10 DA013720NIDA NIH HHS U10 DA013727NIDA NIH HHS U10 DA013732NIDA NIH HHS U10 DA020024NIDA NIH HHS U10 DA020036NIDA NIH HHS UG1 DA020024
6 · The paper itself

Abstract

objectiveFew studies have examined the effectiveness of 12-step peer recovery support programs with drug use disorders, especially stimulant use, and it is difficult to know how outcomes related to 12-step attendance and participation generalize to individuals with non-alcohol substance use disorders (SUDs).

methodA clinical trial of 12-step facilitation (N=471) focusing on individuals with cocaine or methamphetamine use disorders allowed examination of four questions: Q1) To what extent do treatment-seeking stimulant users use 12-step programs and, which ones? Q2) Do factors previously found to predict 12-step participation among those with alcohol use disorders also predict participation among stimulant users? Q3) What specific baseline "12-step readiness" factors predict subsequent 12-step participation and attendance? And Q4) Does stimulant drug of choice differentially predict 12-step participation and attendance?

resultsThe four outcomes variables, attendance, speaking, duties at 12-step meetings, and other peer recovery support activities, were not related to baseline demographic or substance problem history or severity. Drug of choice was associated with differential days of Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) attendance among those who reported attending, and cocaine users reported more days of attending AA or NA at 1-, 3- and 6-month follow-ups than did methamphetamine users. Pre-randomization measures of perceived benefit of 12-step groups predicted 12-step attendance at 3- and 6-month follow-ups. Pre-randomization 12-step attendance significantly predicted number of other self-help activities at end-of-treatment, 3- and 6-month follow-ups. Pre-randomization perceived benefit and problem severity both predicted number of self-help activities at end-of-treatment and 3-month follow-up. Pre-randomization perceived barriers to 12-step groups were negatively associated with self-help activities at end-of-treatment and 3-month follow-up. Whether or not one participated in any duties was predicted at all time points by pre-randomization involvement in self-help activities.

conclusionsThe primary finding of this study is one of continuity: prior attendance and active involvement with 12-step programs were the main signs pointing to future involvement. Limitations and recommendations are discussed.

Indexed as

Self-Help GroupsAlcoholics AnonymousAmphetamine-Related DisordersCentral Nervous System StimulantsCocaine-Related DisordersFemaleFollow-Up StudiesHumansMaleMethamphetaminePatient Acceptance of Health CareSubstance-Related DisordersTime FactorsCentral Nervous System StimulantsMethamphetamine12-stepAttendanceParticipationPeer recoveryPredictorsStimulant users

Identifiers

PMID27431050
PMCPMC5462490
OpenAlexW2426863673

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.